arrow
L

Lúcio Mendes Cabral

Universidade Federal do Rio de Janeiro
H指数:32
被引数:3,426

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis − an overview and systematic approach

从实验室到皮肤:纳米纤维在皮肤利什曼病治疗中的转化潜力——概述和系统方法

2026-07-150
OAAI
Piperazine-Thiourea Hybrids as Novel Antiplatelet Agents Targeting COX-1: Synthesis; in Vitro; and in Silico Evaluation

哌嗪-硫脲类杂合体作为靶向COX-1的新型抗血小板剂:合成;体外;和计算机模拟评价

2026-04-010
OA
Identification and Characterization of Perampanel Degradation Products: Stability-Indicating HPLC and In Silico Toxicological Assessment

帕瑞帕奈降解产物的鉴定与表征:稳定性指示HPLC与计算机毒理学评估

2026-03-140
OA
MICRONEEDLING-ENHANCED KOJIC ACID SERUM: A COMPREHENSIVE STUDY OF RETENTION, PERMEATION, DERMAL TARGETING, AND CYTOTOXICITY

微针增强型熊果苷精华:关于保留、渗透、真皮靶向和细胞毒性的全面研究

2025-12-240
PRE
Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors

设计、合成及新型多靶点7-羟氨基-3-(1,2,3-三唑基)-香豆素的生物活性评价:作为强效乙酰胆碱酯酶抑制剂

2025-09-210
OAAI
Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches

利用药物重定位和虚拟筛选方法揭示新型精氨酸酶抑制剂以治疗皮肤利什曼病

2025-08-220
OAAI
Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children

三维打印的异烟肼咀嚼凝胶,用于儿童按需潜伏结核病治疗

2025-05-170
OA
Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer's disease: In vitro, in vivo, and in silico studies
2025-01-010
PRE
Synthesis, in silico, and in vitro evaluation of 7-chloro-quinolines designed as myeloperoxidase inhibitors
2024-09-010
PRE